GPX2 and cancer: We assessed 19,221 genes and observed a positive correlation between FIN sensitivity and the expression of several well-known NRF2 targets, including NQO1, SLC7A11, GPX2, GCLC, and FTH1, across various cancer cell lines at both the mRNA and protein levels (Figs. 2A and S2A, B).